November 28, 2012 Viratech Corp (OTC:VIRA)and News

November 28, 2012 Viratech Corp (OTC:VIRA)and Newswire are proud to announce a new joint project called “This Week inViratech”.Viratech and Newswire have a signed an agreement to collaborate on theexciting new promotion and education project. “This Week in Viratech” is a 26episode project airing every Saturday morning on a YouTube channel at http://www.youtube.com/user/ViratechNews. The purpose of the program is to announce what has happened in the pastweek at Viratech Corp as Viratech moves out of the research and developmentphase of their new open source biotech research social network platform andinto business development and revenue stages.Using this platform, Viratech members can protect their intellectualproperty, then use Viratech’s micro social network as a utility to promote andcrowdfund the research and development to produce the new technology. Usingvideos and other visuals, “This Week in Viratech” will explain to the laycommunity how its business model works in its three key phases: Protect,Promote and Produce.  “This Week in Viratech” will also provide a questionand answer format for viewers to explore more about the business model and howit works.Under “Protect”, the business model shows how to protect intellectualproperty while the patent is pending by the use of copyright and the creationof a copyright shell.  “Promote” details how a micro social network, orMSN, is used to promote segments of the patent pending idea to attractresearch, knowledge and funding partners as members of the MSN. Once formed,the MSN is then used to “Produce” the product through crowdfunding andViratech’s innovative approach to compensating members for their micro socialnetwork activity.Viratech Corp’s model opens the playing field up to developers on allresource levels and turns the biotech industry into an open source arenawelcoming innovation and providing avenues for those innovations to berealized. Through the collaboration agreement with Newswire, “This Week inViratech” shares the vision with both the general public and those smallbusiness researchers and developers anxious to protect their intellectualproperty while actively working to make it a reality. Viratech Corp andNewswire believe this open source platform will change the landscape ofintellectual property and finally allow medicine to make advancements on asimilar scale to communication technology.About Viratech Corp.Based in Stockton, California, Viratech Corp. has created an open sourcebiotech research and development platform, Viratech has created a uniqueplatform leveraging the utility of social collaboration, which will allowcancer research the opportunity for the first time to become opensourced.  This is accomplished by allowing our development partners theability to protect, promote and produce their research in unified onlinecollaboration hubs known as micro social networks. Viratech’s open sourceplatform has integrated several intellectual property tools which, byleveraging our social collaboration network, can give our development partnersa new intellectual property mechanism, which will help in addressing theprotection of Intellectual Property, promotion through collaboration in ourprotected open source platform, and commercial development of the productsachieved through collaborative research.Using this platform, Viratech members can protect their intellectualproperty, then use Viratech’s micro social network as a utility to promote andcrowdfund the research and development to produce the new technology. Forward-Looking Statements:This press release includes forward-looking statements concerning the futureperformance of our business, its operations and its financial performance andcondition, and also includes selected operating results presented without thecontext of accompanying financial results. These forward-looking statementsinclude, among others, statements with respect to our objectives and strategiesto achieve those objectives, as well as statements with respect to our beliefs,plans, expectations, anticipations, estimates or intentions. Theseforward-looking statements are based on our current expectations. We cautionthat all forward-looking information is inherently uncertain and actual resultsmay differ materially from the assumptions, estimates or expectations reflectedor contained in the forward-looking information, and that actual futureperformance will be affected by a number of factors, including economicconditions, technological change, regulatory change and competitive factors,many of which are beyond our control. Therefore, future events and results mayvary significantly from what we currently foresee. We are under no obligation(and we expressly disclaim any such obligation) to update or alter theforward-looking statements whether as a result of new information, futureevents or otherwise.Contact: Dr. Kevin BuckmanViratech, Corp.http://viratech.orgEmail Contact: info@viratech.orgTo learn more about viratech, please send an email at info@viratech.org 

test